Trial intelligence / Profile preview

Procaterol vs Salbutamol MDI for Acute Asthma in the ER

NCT01091337Phase 4Completed

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
May 2006
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of procaterol in asthma (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Bronchodilator efficacy of inhaled procaterol vs. inhaled salbutamol. Started May 2006; status: completed.

02

Drugs

procaterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01091337.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01091337.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call